Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic mastectomy and genetic testing: an update.

S L Houshmand1, C T Campbell, S E Briggs

  • 1Saskatoon Cancer Centre, Canada. shoushmand@scf.sk.ca

Oncology Nursing Forum
|December 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glioblastoma multiforme presenting with recurrent neurological deficits: Transient ischemic attacks or tumor attacks.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway.

British journal of cancer·2014
Same author

Adsorption energetics of CO on supported Pd nanoparticles as a function of particle size by single crystal microcalorimetry.

Physical chemistry chemical physics : PCCP·2011
Same author

Simple interventions fail to produce sustained reduction in unnecessary intravascular device dwell time.

Infection control and hospital epidemiology·2009
Same author

Surface products and coverage dependence of dissociative ethane adsorption on Pt{110}-(1 x 2).

The journal of physical chemistry. B·2006
Same author

Surface science. Catalysts under pressure.

Science (New York, N.Y.)·2001
Same journal

Exploring Information Needs of Patients With Cancer and Family Caregivers: A Descriptive and Network Analysis of End-of-Life Inquiries.

Oncology nursing forum·2026
Same journal

Postoperative Physiologic Comfort Management for Patients With Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy.

Oncology nursing forum·2026
Same journal

Exploring Racial Disparities in Uterine Cancer Survival: A 20-Year, Single-Site Analysis.

Oncology nursing forum·2026
Same journal

What I See as an Editor: The Reach of Nurse-Led Intervention Oncology Research.

Oncology nursing forum·2026
Same journal

Trends and Hot Spots in Cancer Family Resilience: A Bibliometric and Visualization Study.

Oncology nursing forum·2026
Same journal

Seven-Year Cognitive Trajectories in Older Adult Cancer Survivors: Findings From a National Cohort Study.

Oncology nursing forum·2026
See all related articles

Prophylactic mastectomy offers a survival advantage for women with BRCA1/BRCA2 mutations, despite challenges with genetic testing. This procedure is a key option for high-risk breast cancer prevention.

Area of Science:

  • Oncology
  • Genetics
  • Preventive Medicine

Background:

  • Women with BRCA1 and BRCA2 mutations have a significantly elevated risk of breast cancer.
  • Limited preventive options exist for these high-risk individuals.

Purpose of the Study:

  • To discuss the benefits and challenges of prophylactic mastectomy for BRCA1/BRCA2-positive women.
  • To review current breast cancer prevention strategies for mutation carriers.

Main Methods:

  • Literature review of published research articles.
  • Analysis of professional review articles and textbooks.

Main Results:

  • Prophylactic mastectomy demonstrates a survival advantage in young BRCA1/BRCA2 mutation carriers.

Related Experiment Videos

  • Significant challenges are associated with prophylactic mastectomy and genetic testing implementation.

    • Conclusions:

    • Breast cancer prevention in BRCA1/BRCA2 carriers includes surveillance, prophylactic mastectomy, and potentially chemoprevention.
    • Genetic testing and prophylactic mastectomy present distinct benefits and challenges.
    • Recent evidence supports survival benefits of prophylactic mastectomy for BRCA1/BRCA2-positive women.